Cold & Cough Remedies (Pharmacies) - Sri Lanka

  • Sri Lanka
  • Revenue in the Cold & Cough Remedies market is projected to reach US$61.10m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 7.72%, resulting in a market volume of US$88.61m by 2029.
  • In global comparison, most revenue will be generated in China (US$7,826.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.78 are generated in 2024.

Key regions: Canada, United Kingdom, United States, China, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies (Pharmacies) market in Sri Lanka is experiencing significant growth and development.

Customer preferences:
Customers in Sri Lanka have shown a growing preference for over-the-counter cold and cough remedies purchased from pharmacies. This can be attributed to several factors, including the convenience of purchasing these products directly from pharmacies, the increasing awareness of self-medication, and the affordability of these remedies compared to prescription medications. Additionally, customers in Sri Lanka tend to prioritize quick relief from cold and cough symptoms, making over-the-counter remedies an attractive option.

Trends in the market:
One of the key trends in the Cold & Cough Remedies (Pharmacies) market in Sri Lanka is the increasing demand for natural and herbal remedies. Customers are becoming more conscious of the potential side effects of conventional medications and are seeking alternative options. This trend aligns with the global shift towards natural and holistic healthcare solutions. As a result, pharmacies in Sri Lanka are expanding their product offerings to include a wider range of natural remedies, such as herbal teas, essential oils, and traditional Ayurvedic formulations. Another trend in the market is the growing popularity of combination remedies. Customers in Sri Lanka are looking for products that provide relief from multiple symptoms, such as congestion, sore throat, and cough, in a single dose. Combination remedies offer convenience and cost-effectiveness, as customers do not need to purchase multiple products for different symptoms. Pharmacies are responding to this trend by stocking a variety of combination remedies and promoting them as a one-stop solution for cold and cough relief.

Local special circumstances:
Sri Lanka has a tropical climate, which makes it prone to seasonal changes and fluctuations in temperature. These conditions often lead to a higher incidence of cold and cough among the population. As a result, the demand for cold and cough remedies remains consistently high throughout the year. Pharmacies in Sri Lanka capitalize on this demand by ensuring a steady supply of these products and offering promotions during peak seasons.

Underlying macroeconomic factors:
The growing middle class in Sri Lanka has contributed to the development of the Cold & Cough Remedies (Pharmacies) market. As disposable incomes rise, more individuals have the financial means to purchase over-the-counter remedies. Additionally, the increasing urbanization and changing lifestyles in Sri Lanka have led to a higher prevalence of cold and cough symptoms, further driving the demand for these products. The government's focus on improving healthcare infrastructure and increasing access to pharmacies has also played a role in the market's development. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Sri Lanka is experiencing growth and development due to customer preferences for over-the-counter remedies, the trend towards natural and herbal solutions, and the demand for combination remedies. The local special circumstances, such as the tropical climate and seasonal fluctuations, contribute to the consistent demand for these products. The underlying macroeconomic factors, including the growing middle class and government initiatives, further support the market's expansion.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)